Table 5.
cBioPortal-based CCA patient overall survival and progression-free survival.
| Immune Modulatory Gene | Overall Survival Log-Rank Test (p-Value) | Progression-Free Survival Log-Rank Test (p-Value) |
|---|---|---|
| FASLG | 1.370 × 10−3 | 3.843 × 10−3 |
| LGALS9 | 0.286 | 0.759 |
| LAG3 | 0.464 | 0.898 |
| HAVCR2 | 0.095 | 0.225 |
| VSIR | 0.515 | 0.290 |
| VTCN1 | 0.361 | 0.900 |
| IDO1 | 0.450 | 0.242 |
| TNFRSF9 | NA | NA |
| TNFRSF14 | NA | NA |
| TIGIT | 0.515 | 0.290 |
| CD276 | 0.514 | 0.290 |
| CD27 | 0.515 | 0.290 |
| CD274 | 0.054 | 0.109 |
| PDCD1LG2 | 0.464 | 0.898 |
| NT5E | 2.826 × 10−3 | 4.072 × 10−3 |
| CD80 | 0.515 | 0.290 |
| TNFRSF18 | NA | NA |
| BTLA | 0.515 | 0.290 |
| CD28 | 0.515 | 0.290 |
NA: No patient data available with alteration in this gene.